Lord, Abbett & Co
DGX icon

Lord, Abbett & Co’s Quest Diagnostics DGX Stock Holding History

Lord, Abbett & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-152,160
Closed -$22.1M – 629
2021
Q3 		$22.1M Sell
152,160
-4,240
-3% -$620K 0.05% 407
2021
Q2 		$20.6M Sell
156,400
-701
-0.4% -$91.8K 0.05% 411
2021
Q1 		$20.2M Sell
157,101
-2,660
-2% -$328K 0.05% 419
2020
Q4 		$19M Sell
159,761
-18,460
-10% -$2.25M 0.05% 417
2020
Q3 		$20.4M Sell
178,221
-14,100
-7% -$1.67M 0.07% 377
2020
Q2 		$21.9M Sell
192,321
-1,004,604
-84% -$107M 0.08% 354
2020
Q1 		$96.1M Buy
1,196,925
+205,131
+21% +$21.2M 0.43% 57
2019
Q4 		$106M Buy
991,794
+301,335
+44% +$31.4M 0.35% 73
2019
Q3 		$73.9M Buy
690,459
+348,567
+102% +$35.8M 0.25% 109
2019
Q2 		$34.8M Buy
341,892
+207,671
+155% +$20M 0.11% 312
2019
Q1 		$12.1M Sell
134,221
-304,379
-69% -$26.4M 0.04% 526
2018
Q4 		$36.5M Sell
438,600
-136,000
-24% -$12.8M 0.13% 243
2018
Q3 		$62M Buy
+574,600
New +$63M 0.17% 191
2018
Q2 		– Sell
-27,700
Closed -$2.78M – 859
2018
Q1 		$2.78M Sell
27,700
-6,700
-19% -$686K 0.01% 786
2017
Q4 		$3.39M Sell
34,400
-100
-0.3% -$9.48K 0.01% 807
2017
Q3 		$3.23M Sell
34,500
-73,700
-68% -$7.82M 0.01% 816
2017
Q2 		$12M Sell
108,200
-243,500
-69% -$25.7M 0.04% 587
2017
Q1 		$34.5M Buy
351,700
+22,600
+7% +$2.15M 0.1% 307
2016
Q4 		$30.2M Buy
329,100
+20,800
+7% +$1.79M 0.09% 313
2016
Q3 		$26.1M Sell
308,300
-7,100
-2% -$596K 0.08% 379
2016
Q2 		$25.7M Buy
315,400
+207,900
+193% +$15.8M 0.08% 362
2016
Q1 		$7.68M Sell
107,500
-197,300
-65% -$13.2M 0.02% 624
2015
Q4 		$21.7M Sell
304,800
-53,100
-15% -$3.57M 0.07% 405
2015
Q3 		$22M Sell
357,900
-227,600
-39% -$15.9M 0.07% 394
2015
Q2 		$42.5M Buy
585,500
+291,915
+99% +$21.6M 0.11% 294
2015
Q1 		$22.6M Buy
+293,585
New +$21M 0.06% 456
2014
Q1 		– Sell
-133,800
Closed -$7.16M – 1021
2013
Q4 		$7.16M Buy
+133,800
New +$7.94M 0.02% 745

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Lord, Abbett & Co's DGX Position: Q4 2021 in Review

Lord, Abbett & Co sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 152,160 shares — an estimated $22.1M sold.

Lord, Abbett & Co first reported a position in DGX in Q4 2013 and held it in 27 quarters. The position peaked at $106M in Q4 2019. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

  • Lord, Abbett & Co reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 152,160 Quest Diagnostics shares in Q4 2021, an estimated $22.1M.
  • Lord, Abbett & Co first reported a position in Quest Diagnostics in Q4 2013 and held it in 27 quarters.
  • Lord, Abbett & Co's Quest Diagnostics position peaked at $106M in Q4 2019.
  • 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.